Background
==========

We previously reported induction of HIV-specific responses in Chacma baboons following immunization with SAAVI MVA-C (MVA) and HIV-1 Pr55 Gag virus-like particles (VLPs) in a prime-boost vaccination strategy. In the current study, we characterised the vaccine specific memory T cells by flow cytometry.

Methods
=======

Peripheral blood mononuclear cells (PBMC) from baboons primed with MVA and boosted with VLPs (n=3) or vaccinated with VLPs only controls (n=2) were stimulated with HIV-1 Gag peptide pools. T cell cytokine production (multiplex TNF-a, IFN-y and IL-2) and memory phenotype was determined by flow cytometry. Human anti-CD28 and CD95 antibodies were used to delineate effector memory (Tem) and central memory (Tcm) T cells.

Results
=======

Vaccine specific memory responses were detectable one week after MVA prime. At peak T cell response (four weeks after VLP boost), the frequency of cytokine producing cells in prime-boost animals (mean response: 0.21%±0.012 and 0.242% ±0.049 of CD4+ and CD8+ cells respectively) was higher than in control animals (mean response: 0.066%±0.005 and 0.034%± 0.016 of CD4+ and CD8+ cells respectively). Gag-specific CD4+ cells from the prime-boost animals were significantly skewed towards a Tcm phenotype (\>95%) of total cytokine responses compared to the Tem phenotype (\<2%). A similar memory distribution profile of Gag-specific CD4+ cells was maintained 20 weeks after the VLP boost. At this time, Gag-specific CD8+ cells were evenly distributed between Tcm (\~40%) and Tem (\~60%) phenotypes. Vaccine specific memory responses were preserved 20 weeks after the VLPs boost (mean: 0.128%±0.025 and 0.147%± 0.039 of CD4+ and CD8+ cells respectively) in the prime-boost animals.

Conclusion
==========

In conclusion, the MVA prime and VLP boost induced Gag-specific cytokine producing Tcm and Tem defined by expression of CD28 and CD95. These cells were detected up to 20 weeks post vaccination suggesting these vaccines could be potential HIV-1 vaccine candidates.
